Veterinary Medicines

TETRACYCLINE 50 COOPHAVET

Not authorised
  • Tetracycline hydrochloride
Download as PDF

Product identification

Medicine name:
TETRACYCLINE 50 COOPHAVET
Active substance:
  • Tetracycline hydrochloride
Target species:
  • Cattle
  • Pig
  • Rabbit
  • Horse
  • Sheep (lamb)
  • Sheep
  • Goat (kid)
  • Goat
  • Cattle (calf)
  • Poultry
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Tetracycline hydrochloride
    538.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Milk
        no withdrawal period
    • Pig
      • Meat and offal
        7
        day
    • Rabbit
      • Meat and offal
        7
        day
    • Horse
      • Meat and offal
        7
        day
    • Sheep (lamb)
      • Meat and offal
        7
        day
    • Sheep
      • Milk
        no withdrawal period
    • Goat (kid)
      • Meat and offal
        7
        day
    • Goat
      • Milk
        no withdrawal period
    • Cattle (calf)
      • Meat and offal
        7
        day
    • Poultry
      • Meat and offal
        7
        day
      • Eggs
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01AA07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Dopharma France S.A.S.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Dopharma France S.A.S.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/8798846 2/1992
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download